Ad is loading...
Ad is loading...
CARYX vs FLMAX
CARYX vs FLMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
CARYX vs. FLMAX commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARYX is a Hold and FLMAX is a Buy.
FUNDAMENTALS
Fundamentals
CARYX has more cash in the bank: 2.52B vs. FLMAX (956M). FLMAX pays higher dividends than CARYX: FLMAX (1.72) vs CARYX (0.56). CARYX was incepted earlier than FLMAX: CARYX (10 years) vs FLMAX (8 years). FLMAX is a more actively managed with annual turnover of: 316.00 vs. CARYX (199.00). FLMAX has a lower initial minimum investment than CARYX: FLMAX (2500) vs CARYX (1000000). FLMAX annual gain was more profitable for investors over the last year : 24.14 vs. CARYX (15.03). FLMAX return over 5 years is better than : 44.86 vs. CARYX (1.60).
| CARYX | FLMAX | CARYX / FLMAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 10 years | 8 years | - |
| Gain YTD | 8.462 | 18.694 | 45% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2500 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.52B | 956M | 264% |
| Annual Yield % from dividends | 0.56 | 1.72 | 32% |
| Returns for 1 year | 15.03 | 24.14 | 62% |
| Returns for 3 years | -12.24 | 13.55 | -90% |
| Returns for 5 years | 1.60 | 44.86 | 4% |
| Returns for 10 years | 17.75 | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| INDS | 38.51 | 0.14 | +0.36% |
| Pacer Benchmark Industrial RE SCTR ETF | |||
| PBTP | 25.42 | 0.03 | +0.10% |
| Invesco 0-5 Yr US TIPS ETF | |||
| LMBS | 48.64 | -0.03 | -0.06% |
| First Trust Low Duration Oppos ETF | |||
| PPH | 86.59 | -1.58 | -1.79% |
| VanEck Pharmaceutical ETF | |||
| HELX | 28.55 | -1.41 | -4.72% |
| Franklin Genomic Advancements ETF | |||